by Jordana Choucair | May 9, 2022 | Payers
A study published in JAMA Health Forum found that prescription drug rebates from drugmakers to commercial health plans are steadily increasing. However, while such rebates can reduce plans’ net costs, they do not reduce patients’ cost sharing. According to the...
by Jordana Choucair | May 9, 2022 | Providers
Some hospitals are attempting to raise prices by up to 15 percent in an effort to offset mounting costs for nurse salaries. According to employers and insurers, the requests are more than the 4 percent to 6 percent price increases that hospitals typically seek and...
by Jordana Choucair | May 9, 2022 | Public Health/Prevention
The Biden administration is issuing a new warning that the U.S. could potentially see 100 million COVID-19 infections this fall and winter. The White House is sharing these estimates as officials are publicly stressing the need for more funding from Congress to combat...
by Jordana Choucair | May 6, 2022 | Life Sciences
The Food and Drug Administration (FDA) announced that it is limiting the authorization for the Johnson & Johnson COVID-19 to adults age 18 and older who cannot or will not get the Pfizer or Moderna vaccines. The agency said it was making the change because of the...
by Jordana Choucair | May 6, 2022 | Opioid/Substance Use Disorders
Walgreens reached a $683 million settlement with the state of Florida to resolve claims that the company improperly dispensed millions of opioid pills. Lawyers for Florida said Walgreens dispensed more than 4.3 billion opioid pills in Florida over a 15-year period and...
by Jordana Choucair | May 6, 2022 | Payers
Centene announced it plans to divest two of its pharmacy businesses for a total of $2.8 billion. The insurer will sell its Magellan Rx subsidiary to Prime Therapeutics, a pharmacy benefit manger (PBM) backed by some of the country’s largest Blues plans, and will...
Recent Comments